Join
Live feed
·
NEWSReleasevia Quantisnow
DMK Pharmaceuticals Corporation logo

Maxim Group Initiates Coverage On DMK Pharmaceuticals with Buy Rating, Announces Price Target of $1.5

ByQuantisnow·Wall Street's wire, on your screen.
DMK· DMK Pharmaceuticals Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMK (DMK Pharmaceuticals Corporation) and more on Quantisnow.

Maxim Group Initiates Coverage On DMK Pharmaceuticals with Buy Rating, Announces Price Target of $1.5 | Quantisnow